Warning Letter — ejuicedemand.com
The FDA Center for Tobacco Products issued a Warning Letter to ejuicedemand.com following an evaluation of their product offerings and compliance status.
This affects the entity ejuicedemand.com, as well as regulatory and compliance departments within the e-liquid and tobacco retail industry.
This letter indicates the FDA's continued scrutiny of online retailers within the tobacco space. For industry professionals, it underscores the risk of enforcement action for distributing nicotine-containing products that may lack the required marketing authorization or fail to meet Center for Tobacco Products (CTP) standards.
Regulatory teams should verify that all tobacco and nicotine products in their portfolio have current, valid marketing authorizations. QA and compliance departments should review digital sales channels to ensure no unauthorized products are being offered to consumers.
FDA Warning Letter issued to: ejuicedemand.com. 07/10/2026 — Center for Tobacco Products. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ejuicedemandcom-733740-07102026
Open in openFDA / FDA.gov